Ortofen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ortofen

Ortofen: A Quick Introduction to the Medication

Property Description
Active ingredient Diclofenac (INN)
Form Tablets (oral), Gels (topical), or Injections
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Pain, Inflammation, and Fever Reduction
Origin Synthetic (chemically synthesized)

Ortofen is a trade name for a medication whose active ingredient is Diclofenac, a compound with long-standing medical recognition for its anti-inflammatory and pain-relieving effects. The drug is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is available in multiple pharmaceutical forms globally, making it versatile for targeted treatment. The fundamental goal of Ortofen is to provide symptomatic relief from physical discomfort and inflammation.


What Class of Drug is Ortofen and What is it Made Of?

Ortofen is a synthetic medication that belongs to the chemical and pharmacological class of NSAIDs, specifically the acetic acid derivatives, known for inhibiting the body's inflammatory response. The core ingredient, Diclofenac, is typically present as a salt (sodium or potassium) and is widely utilized for its effects on inflammation mediators.

This classification means that Ortofen is clinically recognized for its ability to temper the body's reaction to painful and inflammatory stimuli, such as those caused by musculoskeletal conditions. Its effects are rooted in its consistent chemical action, which is well-studied across various brand names containing Diclofenac.


General Therapeutic Use: Why is Ortofen Prescribed?

The general therapeutic purpose of Ortofen is to reduce symptoms associated with acute and chronic inflammation, providing powerful analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) actions. Medicines containing Diclofenac are used for treating painful conditions associated with inflammation.

This indicates the medicine is intended to quickly address the symptoms of pain and swelling rather than cure the underlying disease itself. Ortofen's broad utility ensures it is a staple in managing pain and stiffness, helping patients achieve better daily comfort and mobility.

What side effects are possible with Ortofen?

Possible Side Effects and Safety Information

Ortofen, which contains the active ingredient Diclofenac, is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and carries documented risks across multiple physiological systems, as outlined in official regulatory labeling.

Serious Adverse Reactions

Regulatory documents highlight a significantly increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with the duration of use and is most consistent at higher doses. The medication is also associated with an elevated risk of serious gastrointestinal events, such as ulceration, bleeding, and perforation of the stomach or intestines, which can occur without warning symptoms.

Commonly Classified Adverse Effects

The most frequently classified adverse reactions primarily involve Gastrointestinal Disorders (e.g., nausea, abdominal pain, dyspepsia, diarrhea, constipation) and Nervous System Disorders (e.g., headache, dizziness). Other common effects include edema (fluid retention) and elevated liver enzymes (hepatotoxicity).

Specific Safety Constraints

Use of Diclofenac is contraindicated for the treatment of perioperative pain following Coronary Artery Bypass Graft (CABG) surgery and in patients with established congestive heart failure (NYHA Class II-IV). Older adults are at a greater baseline risk for serious gastrointestinal and cardiovascular events. Additionally, use is generally avoided starting at 30 weeks of pregnancy due to risks to the fetus, and the medicine may mask the signs of infection.

Overdose and Emergency Response

The official regulatory profile for Ortofen (Diclofenac) overdose details specific manifestations and mandates immediate emergency action. Documented overdose presentations commonly involve the gastrointestinal system, causing nausea, vomiting, epigastric pain, and potentially gastrointestinal bleeding. Central nervous system effects such as headache, drowsiness, dizziness, and tinnitus are also reported. Severe intoxication can escalate to life-threatening outcomes affecting major organs, including acute renal failure and liver damage. Other severe complications include hypotension and respiratory depression.

Immediate medical attention must be sought for any suspected overdosage. Individuals should contact emergency services or a poison control center without delay, especially if severe signs like convulsions or loss of consciousness occur. Regulatory documentation explicitly states that no specific antidote is known for Diclofenac overdose. Therefore, management is defined as symptomatic and supportive treatment. Procedures such as gastric lavage and administration of activated charcoal are officially described if ingestion was recent. Furthermore, intensive hospital monitoring may be required to manage vital functions and observe for organ toxicity. A specific consideration exists for patients with pre-existing impaired renal or hepatic function, who may face an increased risk of severe systemic effects during an overdose event.

Therapeutic Uses of Ortofen

What Ortofen Treats: Main Uses and Benefits

Medications containing diclofenac are generally used to relieve symptoms related to physical discomfort and inflammation. Ortofen contributes to symptomatic relief by addressing symptoms of discomfort and swelling.

Therapeutic Domains

The medication is commonly used across conditions involving inflammatory processes, such as Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis, where it plays a role in managing symptoms of joint pain and stiffness. It is also applied in scenarios where additional management of discomfort is required, such as pain from minor sprains, contusions, and post-operative inflammation. Additionally, it may assist with managing distressing manifestations associated with specific acute attacks like gout, migraine headaches, and painful menstrual periods (dysmenorrhea).

Ortofen provides support that helps ease the overall symptom load during phases when symptoms become more noticeable, assisting with maintaining a sense of stability.


Quick Fact: Relief for Pain and Stiffness

Ortofen is relevant for easing symptom clusters that may become intense or disruptive, helping patients cope steadily with symptom fluctuations and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Ortofen?

Ortofen (diclofenac) eligibility is strictly defined by regulatory authorities based on specific patient populations and existing medical conditions.

Use is Strictly Contraindicated (prohibited) in patients with a history of allergic reactions (including asthma or urticaria) to aspirin or other NSAIDs. It is absolutely prohibited for patients with active gastrointestinal ulceration or bleeding, severe hepatic or renal failure, and severe heart failure. Use is also forbidden during the third trimester of pregnancy and for managing pain related to coronary artery bypass graft (CABG) surgery.

Conditional and Restricted Use is mandated for other populations. The medicine is generally not recommended for children below a certain age threshold (e.g., 14 or 16 years) as safety and efficacy have not been established. Older adults require careful monitoring and must use the lowest effective dose due to increased risk. Caution is required for patients with mild to moderate organ impairment (kidney/liver) or hypertension. Eligibility status in the first two trimesters of pregnancy or during lactation requires a careful assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents indicate that Ortofen (Diclofenac) has clinically significant interactions across several drug classes and substances. These interactions may result in additive safety risks or reduced therapeutic effectiveness of co-administered agents.


Interaction Scope

Classification Interacting Agents and Documented Outcome
Formal Regulatory Prohibitions Contraindicated for use in the perioperative setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with a history of allergic-type reactions to Aspirin or other NSAIDs.
Additive Risk Concomitant use with Anticoagulants, SSRIs/SNRIs, Anti-platelet agents, or Systemic Corticosteroids increases the risk of serious gastrointestinal (GI) bleeding or ulceration.
Efficacy Impairment May diminish the antihypertensive effect of ACE Inhibitors, ARBs, or Beta-Blockers. Reduces the natriuretic effect of Diuretics.
Exposure Modification Can increase the serum concentration and prolong the half-life of Digoxin. Co-administration with the CYP2C9 inhibitor Voriconazole is documented to increase Diclofenac’s systemic exposure.
Substance & Timing Constraints Consumption of alcohol is associated with an increased GI risk. Topical formulations require the treated area to be completely dry before applying other topical products.

The regulatory profile defines strict non-combination requirements and cautions for specific patient populations. The risk of deterioration of renal function with ACE Inhibitors/ARBs is specifically noted as heightened in elderly, volume depleted, or renally impaired patients.

Mechanism of Action

The mechanism of Ortofen, whose active ingredient is Diclofenac, centers on a highly specific modulation of chemical synthesis, which results in the modulation of the eicosanoid synthesis cascade and nociceptive pathway activity.

Modulating Inflammatory Signal Production

The core action involves the inhibition of Cyclooxygenase ( COX) enzymes, particularly the inducible COX-2 isoform, which is responsible for synthesizing key pro-inflammatory mediators. By competitively blocking COX activity, the drug limits the production of prostaglandins (such as PGE2) at the molecular level, directly affecting the cascade responsible for producing pro-inflammatory prostaglandins. This reduction in chemical mediators decreases local vascular permeability and fluid exudation.

Modulating Peripheral Nociceptive Pathways

The decreased level of prostaglandins acts directly on the peripheral afferent nerve endings (nociceptors). Prostaglandins normally facilitate the excitation of these nerve endings; therefore, their suppression modulates the sensitivity of peripheral nociceptors. This pathway modulation, complemented by an influence on the nitric oxide-cGMP system, results in the modulation of nociceptive afferent signaling.

Regulating Central Body Temperature

The drug's mechanism also extends to the hypothalamus within the central nervous system, which controls the body's internal temperature set-point. By limiting PGE2 synthesis in this area, the mechanism effectively resets the fever set-point, contributing to the functional reset of the hypothalamic set-point.

Dosage and Administration Information

How to use Ortofen: Official Administration Guidelines

The administration of Ortofen (Diclofenac) is defined by standardized instructions that cover multiple routes and specific dosage forms, ensuring adherence to established protocols. The core principle across all systemic forms is to use the lowest effective dose for the shortest possible duration.

Feature Standardized Guideline
Routes and Forms Administration is approved via Oral (tablets, capsules, packets), Topical (gel), Intramuscular (IM) injection, Intravenous (IV) infusion, and Rectal (suppositories).
Dosing Range Total daily oral dose for chronic conditions (e.g., arthritis) generally ranges from 100 mg to 150 mg in divided amounts (e.g., 50 mg two to three times daily or 75 mg twice daily).
Frequency Systemic forms are typically dosed once daily (extended-release) or two to four times daily (immediate/delayed-release), strictly following the prescribed regimen.
Special Timing The administration of some oral forms, such as powder packets, requires mixing only with water and consumption on an empty stomach to ensure proper intake conditions.
Procedural Constraint Oral tablets that are designed for delayed or extended release must be swallowed whole and cannot be crushed, chewed, or broken.
Duration Limit The use of parenteral forms (IM or IV injection) is generally restricted to a maximum duration of two days before transition to an oral or rectal formulation.

Connection to the overall use protocol:

Established guidelines state that the drug's use is highly procedural, mandating strict adherence to the administration technique based on the specific dosage form. This framework ensures that the treatment intensity and duration are minimized, particularly for parenteral use, while maintaining the integrity of specialized oral formulations.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ortofen

Evidence for use in Rheumatoid Arthritis (RA)

Research has been studied for Ortofen in adults with Rheumatoid Arthritis, a condition characterized by fluctuating or episodic manifestations of joint inflammation and stiffness. Studies used in research exploring how symptoms change over time are typically Randomized Controlled Trials (RCTs), which compare the drug against an inactive substance (placebo) or another substance evaluated in the trial.

These trials primarily monitored outcomes related to physical discomfort and daily functioning or activity level. Findings describe patterns observed in the studies over short and intermediate time intervals, often up to a few months. The available data for long-term structural changes to the joints are limited in this context. The general results apply only to the populations studied, meaning the findings describe group patterns, not personal outcomes for all patients with RA.


Evidence for use in Osteoarthritis (OA)

For Osteoarthritis, the evidence base includes both oral and topical formulations. RCTs are the most common study design applied in studies examining patient-reported experiences, focusing on pain intensity and physical function scales. Studies report how symptoms evolved in the observed populations over defined time intervals. What remains uncertain is whether the patterns observed in short-term studies are relevant to the long-term progression of the disease, as follow-up durations were limited in many controlled trials.


What is Still Uncertain About Ortofen Research

A transparent review highlights several remaining questions. Evidence quality varies across studies, and for certain outcomes, findings were mixed. Follow-up durations were limited in many high-quality trials, meaning long-term outcomes are not fully established. Furthermore, data for certain groups, such as the pediatric population and individuals with multiple existing health conditions (comorbidities), remain insufficient.

Key Studies & References

  1. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

Frequently Asked Questions (FAQ)

Common questions about Ortofen (FAQ)


Q: How long does it typically take for Ortofen to start working after a dose?

The time it takes for Ortofen to start working depends on the specific formulation. According to official regulatory information, immediate-release potassium salt formulations can reach their peak concentration in the blood in 30 to 54 minutes. Delayed-release tablets, which dissolve later in the digestive tract, typically reach their peak concentration in about 2.3 hours.


Q: What is the expected duration of pain relief from a single dose of Ortofen?

Official information indicates that the terminal half-life (the time it takes for half of the drug to be eliminated) of the active ingredient is approximately 1 to 2 hours. Studies involving a single 50 mg dose of the potassium salt have reported that it provides pain relief for up to 6.7 hours.


Q: What are the warning signs of serious gastrointestinal issues, like bleeding, while using Ortofen?

Regulatory warnings indicate that serious gastrointestinal (GI) issues, such as bleeding or perforation, can happen without any warning symptoms. In the event these serious risks occur, symptoms documented in regulatory warnings can include very dark, tarry stools, blood in the stool, or vomiting material that resembles coffee grounds.


Q: Does taking Ortofen make a person more sensitive to sunlight or tanning?

Official drug information and adverse effect profiles have listed increased sensitivity of the skin to sunlight (photosensitivity) and severe sunburn as less common side effects. Because of this reported sensitivity, official information suggests avoiding excessive exposure to sunlight.


Q: Why is Ortofen sometimes combined with another ingredient like misoprostol?

Diclofenac is sometimes combined with the drug misoprostol in certain formulations. The purpose of this combination, as stated in regulatory documents, is to help protect the stomach and intestine from the ulcers, bleeding, or holes that can be caused by the NSAID component.


Q: What are the differences between Ortofen sodium and Ortofen potassium formulations?

The main difference between the sodium and potassium salts relates to the rate of absorption. The potassium salt is associated with a faster rate of absorption and onset, while the sodium salt is typically found in delayed-release or enteric-coated tablets and has a slower absorption profile. The long-term safety profiles are generally similar.


Q: Does Ortofen interact with common over-the-counter pain or cold medications?

Regulatory documents indicate that the co-administration of Ortofen with other NSAIDs, such as ibuprofen, aspirin, or naproxen, is not recommended. Since all of these are in the same drug class, combining them significantly increases the risk of serious side effects, particularly those affecting the stomach.


Q: Is Ortofen a prescription-only medication, or can it be purchased over-the-counter?

Due to the potential for serious cardiovascular side effects, oral tablets of diclofenac (Ortofen) are typically classified as prescription-only medicine (POM) in many regions, requiring a medical evaluation. However, low-strength topical gels may sometimes be available for purchase over-the-counter (OTC).


Q: Is Ortofen used for conditions other than arthritis, such as menstrual pain or gout?

Yes, official regulatory indications for certain formulations of diclofenac include the treatment of primary dysmenorrhea (menstrual pain). Some formulations are also indicated for the acute treatment of migraine attacks (headaches).


Q: What is the importance of taking Ortofen with a full glass of water?

Administration guidelines recommend that tablets be swallowed whole with liquid such as water. Furthermore, specific formulations like powder packets must be mixed only with water and consumed on an empty stomach to ensure they are absorbed correctly.


Q: Can I take dietary supplements or vitamins while using Ortofen?

Official health guidance states that there is often not enough information to confirm that certain herbal remedies and supplements are safe to take alongside diclofenac. Official health guidance generally recommends sharing a complete list of all medications, including vitamins and herbal supplements, with a healthcare provider.


Q: What is the official classification of Ortofen regarding its use for headaches or migraines?

Official labeling for a specific powder formulation of diclofenac indicates its use for the acute treatment of migraine attacks in adults. It is not intended for the routine preventative (prophylactic) therapy of migraines.


Q: What symptoms might indicate a person is experiencing a serious, rare side effect of Ortofen?

Serious adverse event warnings document symptoms consistent with serious cardiovascular events, which can include chest pain, sudden weakness on one side of the body, slurred speech, or trouble breathing. These symptoms are consistent with serious cardiovascular events documented in official warnings.


Q: Does the efficacy of Ortofen change if it is taken with dairy products?

In general, regulatory information indicates that food does not significantly change the total absorption of most oral tablets. However, to ensure maximum effectiveness, specific formulations like powder packets are explicitly instructed to be taken on an empty stomach.


Q: Is there a known connection between Ortofen and ringing in the ears (tinnitus)?

Official adverse effect profiles indicate that the experience of a continuous ringing, buzzing, or other unexplained noise in the ears (tinnitus) has been reported as a less common side effect associated with this medication.


Q: Does Ortofen have any effect on a person's ability to drive or operate machinery?

Official product information warns that Ortofen may cause side effects such as dizziness, tiredness, or sleepiness, and problems with eyesight. Regulatory warnings state that if a patient experiences these effects or vision problems, their ability to drive or operate machinery may be affected.


Q: What should be known about the ingredients used in Ortofen formulations besides the active drug?

In addition to the active drug, diclofenac, formulations contain inactive ingredients (excipients) such as various salts, binders, and coatings. Patients who have known allergies to any component, whether active or inactive, should review the full ingredient list with their doctor.

How should Ortofen be stored and disposed of?

How to Store and Dispose of Ortofen?

Storage

Ortofen (diclofenac) should be stored at room temperature, generally between 68 F and 77 F (20 C and 25 C). The container should be tightly closed and kept in a cool, dry place away from moisture, excessive heat, and direct light. Do not store this medication in the bathroom, as high humidity and temperature fluctuations can degrade the product. Always keep Ortofen and all other medications out of sight and reach of children and pets.

Disposal

When disposing of expired or unused Ortofen, the safest and preferred method is a drug take-back program. Many pharmacies and law enforcement agencies offer secure disposal drop-off sites or mail-back envelopes. If a take-back option is not available, you may dispose of the medication in your household trash. To do this, remove the medicine from its original container, mix it with an undesirable substance (such as used coffee grounds or cat litter), place the mixture in a sealed bag or container, and then throw it in the trash. Do not crush tablets and do not flush Ortofen down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ortofen found in:

A-Z Index: